Financial Consulate’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.4K Sell
1,174
-1,798
-60% -$108K 0.01% 291
2025
Q4
$175K Sell
2,972
-940
-24% -$57.1K 0.02% 172
2025
Q3
$218K Buy
+3,912
New +$210K 0.03% 156
2023
Q2
Sell
-6,141
Closed -$456K 104
2023
Q1
$456K Buy
6,141
+1,089
+22% +$83.9K 0.16% 74
2022
Q4
$419K Buy
5,052
+132
+3% +$10.5K 0.15% 86
2022
Q3
$349K Buy
4,920
+160
+3% +$13.8K 0.15% 77
2022
Q2
$413K Buy
4,760
+828
+21% +$77.6K 0.19% 73
2022
Q1
$426K Buy
3,932
+128
+3% +$13.2K 0.16% 78
2021
Q4
$492K Buy
3,804
+36
+1% +$4.41K 0.17% 73
2021
Q3
$456K Buy
3,768
+404
+12% +$49.2K 0.17% 70
2021
Q2
$379K Buy
3,364
+12
+0.4% +$1.26K 0.14% 78
2021
Q1
$320K Buy
3,352
+624
+23% +$56.9K 0.13% 78
2020
Q4
$217K Buy
+2,728
New +$198K 0.09% 98

Other funds holding TECH

Financial Consulate's TECH Position: Q1 2026 in Review

Financial Consulate reduced its Bio-Techne (TECH) stake by 60% in Q1 2026, selling an estimated $108K and leaving 1,174 shares worth $61.4K. The position accounts for 0.01% of the portfolio, ranked #291.

Financial Consulate first reported a position in TECH in Q4 2020 and has held it in 13 quarters since. The position peaked at $492K in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Financial Consulate held 1,174 shares of Bio-Techne worth $61.4K as of Q1 2026.
  • Financial Consulate sold 1,798 Bio-Techne shares in Q1 2026, an estimated $108K.
  • Bio-Techne made up 0.01% of Financial Consulate's portfolio in Q1 2026, its #291 holding.
  • Financial Consulate first reported a position in Bio-Techne in Q4 2020 and has held it in 13 quarters since.
  • Financial Consulate's Bio-Techne position peaked at $492K in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.